Skip to content

13F-HR filed by Tekla Capital Management LLC

Tekla Capital Management LLC filed this 13F-HR for the quarter ended 2013-12-31, filed 2014-01-28, with 57 holding rows worth $952,494,000.

Accession
0001104659-14-004519
Filed
2014-01-28
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2013

A holdings report, 57 entries on the cover page, a total value of $952,494,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $952,494,000 with VALUE read as thousands by filing date, 13F file number 028-10950. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
Gilead Sciences,Inc.375558103COM1,504,712$113,079,000thousands by filing date
CELGENE CORP151020104COM510,046$86,177,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock260,699$71,755,000thousands by filing date
BIOGEN INC COM09062X103Stock191,983$53,707,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM371,329$49,409,000thousands by filing date
Amgen Inc.031162100COM412,143$47,050,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM499,764$37,132,000thousands by filing date
ACTAVIS PLCG0083B108SHS205,707$34,559,000thousands by filing date
PERRIGO CO PLC SHSG97822103Stock221,124$33,934,000thousands by filing date
ISHARES TR464287556ISHARES BIOTECH136,106$30,904,000thousands by filing date
INCYTE CORP COM45337C102Stock588,300$29,786,000thousands by filing date
AKORN INC009728106COM935,758$23,048,000thousands by filing date
SHIRE PLC82481R106COMMON STOCK-FO154,153$21,780,000thousands by filing date
MYLAN INC628530107COM488,209$21,188,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK185,820$19,238,000thousands by filing date
ALLERGAN INC018490102COM166,577$18,503,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM258,241$18,147,000thousands by filing date
AETNA INC NEW00817Y108COM246,841$16,931,000thousands by filing date
CUBIST PHARMACEUTICALS INC229678107COM226,772$15,618,000thousands by filing date
ALERE INC01449J105COM369,553$13,378,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR311,476$12,484,000thousands by filing date
VERASTEM INC92337C104COM1,018,827$11,615,000thousands by filing date
ILLUMINA INC452327109COM103,841$11,487,000thousands by filing date
PHARMACYCLICS INC716933106COM98,000$10,366,000thousands by filing date
HOLOGIC INC436440101COM444,687$9,939,000thousands by filing date
MCKESSON CORP COM58155Q103Stock56,862$9,178,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK768,050$8,917,000thousands by filing date
FOREST LABS INC345838106COM146,500$8,794,000thousands by filing date
IMPAX LABORATORIES INC45256B101COM344,683$8,665,000thousands by filing date
ENDO HEALTH SOLUTIONS INC29264F205COM126,215$8,514,000thousands by filing date
SAGENT PHARMACEUTICALS INC786692103COM319,231$8,102,000thousands by filing date
ALKERMES PLCG01767105SHS194,870$7,923,000thousands by filing date
CATAMARAN CORP148887102COM146,000$6,932,000thousands by filing date
ACCURAY INC DEL004397105COM731,943$6,375,000thousands by filing date
UnitedHealth Group Inc91324P102COM82,436$6,207,000thousands by filing date
IDEXX LABS INC COM45168D104Stock56,265$5,985,000thousands by filing date
INTELLIPHARMACEUTICS INTERNA458173101CMN1,404,000$5,195,000thousands by filing date
INFINITY PHARMACEUTICALS INC45665G303COM349,899$4,832,000thousands by filing date
MERRIMACK PHARMACEUTICALS IN590328100COM757,050$4,043,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM427,790$3,996,000thousands by filing date
CVS Health Corporation126650100COM53,694$3,843,000thousands by filing date
MOLINA HEALTHCARE INC60855R100COM105,000$3,649,000thousands by filing date
AUXILIUM PHARMACEUTICALS05334D107COMMON STOCK173,020$3,588,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock60,000$3,537,000thousands by filing date
BIODELIVERY SCIENCES INTL IN09060J106COM581,860$3,427,000thousands by filing date
ACORDA THERAPEUTICS INC00484M106COM112,881$3,296,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock48,695$3,133,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM32,658$1,968,000thousands by filing date
MEI PHARMA INC55279B202COM NEW243,920$1,954,000thousands by filing date
NPS PHARMACEUTICALS INC62936P103COM62,800$1,907,000thousands by filing date
AVANIR PHARMACEUTICALS INC05348P401CL A NEW406,000$1,364,000thousands by filing date
Thermo Fisher Scientific Inc.883556102COM9,980$1,111,000thousands by filing date
REVVITY INC714046109COM26,300$1,084,000thousands by filing date
SUPERNUS PHARMACEUTICALS868459108COM140,800$1,062,000thousands by filing date
WATERS CORP COM941848103Stock9,700$970,000thousands by filing date
ONCOGENEX PHARMACEUTICALS IN68230A106COM113,100$943,000thousands by filing date
MACROGENICS INC556099109COM31,857$786,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001104659-14-004519this filing2014-01-28acceptance time not in the bulk data set